291 related articles for article (PubMed ID: 7073415)
1. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
[TBL] [Abstract][Full Text] [Related]
2. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
3. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
4. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
[TBL] [Abstract][Full Text] [Related]
6. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
[TBL] [Abstract][Full Text] [Related]
7. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
8. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Glueck CJ; Fallat RW; Mellies M; Tsang RC
Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
[TBL] [Abstract][Full Text] [Related]
9. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
10. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
12. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
Lithell H; Vessby B; Boberg J; Hellsing K
Atherosclerosis; 1980 Oct; 37(2):175-86. PubMed ID: 7000089
[TBL] [Abstract][Full Text] [Related]
13. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
Goodman DS; Noble RP; Dell RB
J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
[TBL] [Abstract][Full Text] [Related]
14. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
15. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
Rose HG; Haft GK; Juliano J
Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
[TBL] [Abstract][Full Text] [Related]
16. [Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
Drouin P; Sauvanet JP; Lambert D; Mejean L; Debry G
Therapie; 1980; 35(4):457-64. PubMed ID: 7466730
[No Abstract] [Full Text] [Related]
17. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
[No Abstract] [Full Text] [Related]
18. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
19. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
20. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]